Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0LR2Q
|
|||
| Former ID |
DIB006303
|
|||
| Drug Name |
LXR-015-2
|
|||
| Synonyms |
Elirex; LXR-1035
Click to Show/Hide
|
|||
| Indication | Ischemia [ICD-11: 8B10-8B11; ICD-9: 459.89] | Terminated | [1] | |
| Company |
LXR Biotechnology Inc
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Carnitine acyltransferase (CRAT) | Target Info | Inhibitor | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800011210) | |||
| REF 2 | EDG receptors as a potential therapeutic target in retinal ischemia-reperfusion injury. Brain Res. 2006 Nov 6;1118(1):168-75. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.